Topics

Catalent Biologics Launches GPExR Boost Cell Line Expression Technology to Improve Titers and Cell-Specific Productivity

10:22 EST 7 Nov 2019 | Drug Discovery Today

SOMERSET, N.J. – November 4, 2019 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced the launch of its next-generation cell line development technology, GPEx® Boost.

Original Article: Catalent Biologics Launches GPExR Boost Cell Line Expression Technology to Improve Titers and Cell-Specific Productivity

NEXT ARTICLE

More From BioPortfolio on "Catalent Biologics Launches GPExR Boost Cell Line Expression Technology to Improve Titers and Cell-Specific Productivity"

Quick Search

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...